Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in the Context COVID-19 (HoCoPsy)

Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in Pandemic and Confinement Context

The actual worldwide context (disease outbreak, confinements instaured in many countries) is a stressful factor for many people. It can have consequences on mental health : separation from loved ones, loss of freedom, uncertainty about infection status, boredom. Patients with mental disorders are especially vulnerable.

On march 17th, the french government ordonned a national confinement to slow the progression of the COVID-19 outbreak, for 15 days at first then renewed several times. This situation has led to a reorganization of care as requested on March 22nd, 2020 in the recommendations applicable to the organization of care in psychiatric services : priority to telephone contacts and teleconsultation by multiplying contacts and assessments.

By the time the reorganization of care became operational, the most vulnerable patients may have experienced a decompensation of their disease.

It is important to know if the COVID-19 outbreak combined with the confinement increased the number of unvoluntary commitment the month after the announce of the confinement.

This could help us understand which patients are more vulnerable is this context, and improve our organization (ambulatory and hospitalization care) if this situation occurs again.

Study Overview

• Status: Completed
• Conditions: Mental Disorders; COVID 19; Disease Outbreak
• Intervention / Treatment: Other: Description of groups caracteristics

Detailed Description

The main objective is to notice if we can observe a increase in the number of unvonluntary commitment the month after the announce of the confinement in the psychiatric hospital La Colombière, CHU Montpellier, France.

Secondary objectives :

• Describe the causes of unvonluntary commitment, and the principal psychiatric diagnostic of the patients
• Assess the lengh of the hospitalization
• Assess the number of patients hospitalized without psychiatric antecedent
• Assess the number of treatment interruptions in the recent history before hospitalization
• Asses the number of patients living alone
• Asses the number of patients using drugs

It is expected to highlight :

• An increase of the number of unvontuntary commitment
• If one or several mental disorders were more at risk of requiring an unvonluntary commitment
• An increased lengh of hospitalization
• An increased number of unvonluntary commitment of patients without psychiatric antecedent
• An increased number of treatment interruptions
• A link between hospitalization and living alone
• A link between hospitalization and using drugs

The medical file of all the patients unvonlutary commited from march 12th to April 09th 2020 are screened, and compared to the patients unvonlutary commited during the same period in 2019.

The caracteristics of interest are their age and sex, if the patient lives alone, the matter of hospitalization, its lengh, their primary psychiatric diagnostic, the use of toxics at the moment of the hospitalization and if this psychiatric decompensation happens in a context of treatment interruption.

• Study Type: Observational
• Enrollment (Actual): 94

Contacts and Locations

Study Locations

• France
  • Montpellier, France, 34295
    • University Hospital

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Probability Sample

Study Population

Adults having been aditted to the psychiatric hospital La Colombière, CHU Montpellier, France, with unvonluntary commitment procedure from march 12th to April 09th (2019 and 2020)

Description

Inclusion criteria:

- Unvonluntary commitment in psychiatric hospital La Colombière, CHU Montpellier, from march 12th to april 19th (2019 and 2020).

Exclusion criteria:

- refusal to participate

Study Plan

How is the study designed?

Number of groups / cohorts

2

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Unvonluntary commitment from March 12th to April 09th 2019; Patients hospitalized with unvonluntary commitment procedure from March 12th to April 09th 2019	Other: Description of groups caracteristics; Comparison of the two groups on all the following criterias : age, sex, if the patient lives alone, the matter of hospitalization, its lengh, their primary psychiatric diagnostic, the use of toxics at the moment of the hospitalization and if this psychiatric decompensation happens in a context of treatment interruption.
Unvonluntary commitment from March 12th to April 09th 2020; Patients hospitalized with unvonluntary commitment procedure from March 12th to April 09th 2020	Other: Description of groups caracteristics; Comparison of the two groups on all the following criterias : age, sex, if the patient lives alone, the matter of hospitalization, its lengh, their primary psychiatric diagnostic, the use of toxics at the moment of the hospitalization and if this psychiatric decompensation happens in a context of treatment interruption.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Number of hospitalized patients	Number of hospitalized patients From March 12th to April 09th	1 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Cause of hospitalization	Primary psychiatric diagnostic From March 12th to April 09th	1 months

Other Outcome Measures

Outcome Measure	Measure Description	Time Frame
Lengh of hospitalization	Patients without psychiatric antecedent (number) From March 12th to April 09th	1 months
Treatment interruption	Presence of absence of history of treatment interruption leading to the hospitalization From March 12th to April 09th	1 months
Number of hospitalized patients living alone	Number of hospitalized patients living alone (opposed to those living with family) From March 12th to April 09th	1 months
Use of drugs	Number of patients using drugs From March 12th to April 09th	1 months

Collaborators and Investigators

• Sponsor: University Hospital, Montpellier
• Investigators: Principal Investigator: Emilie OLIE, MD PhD, University Hospital, Montpellier

Study record dates

Study Major Dates

• Study Start (Actual): May 1, 2020
• Primary Completion (Actual): May 30, 2020
• Study Completion (Actual): June 30, 2020

Study Registration Dates

• First Submitted: June 3, 2020
• First Submitted That Met QC Criteria: June 3, 2020
• First Posted (Actual): June 4, 2020

Study Record Updates

• Last Update Posted (Actual): July 29, 2020
• Last Update Submitted That Met QC Criteria: July 28, 2020
• Last Verified: July 1, 2020

More Information

Terms related to this study

• Keywords: Confinement; Disease outbreak; Unvonluntary commitment
• Additional Relevant MeSH Terms: Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Virus Diseases; Infections; Respiratory Tract Infections; Respiratory Tract Diseases; Pneumonia, Viral; Pneumonia; Lung Diseases; COVID-19; Mental Disorders
• Other Study ID Numbers: RECHMPL20_0320

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED
• IPD Plan Description: NC

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No